Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Investig Allergol Clin Immunol ; 32(4): 291-298, 2022 Jul 22.
Article in English | MEDLINE | ID: covidwho-1964860

ABSTRACT

BACKGROUND AND OBJECTIVE: Most smell tests are difficult to implement in daily clinical practice owing to their long duration. The aim of the present study was to develop and validate a short, easy-to-perform, and reusable smell test to be implemented during the COVID-19 pandemic. METHODS: The study population comprised 120 healthy adults and 195 patients with self-reported olfactory dysfunction (OD). The 8-Odorant Barcelona Olfactory Test (BOT-8) was used for detection, memory/recognition, and forced-choice identification. In addition, a rose threshold test was performed, and a visual analog scale was applied. The Smell Diskettes Olfaction Test (SDOT) was used for correlation in healthy volunteers, and the University of Pennsylvania Smell Identification Test (UPSIT) was used for patients with OD to establish cut-offs for anosmia and hyposmia. In order to take account of the COVID-19 pandemic, disposable cotton swabs with odorants were compared with the original test. RESULTS: In healthy persons, the mean (SD) BOT-8 score was 100% for detection, 94.5% (1.07) for memory/recognition, and 89.6% (0.86) for identification. In patients with OD, the equivalent values were 86% (32.8), 73.2% (37.9), and 77.1% (34.2), respectively. BOT-8 demonstrated good test-retest reliability, with agreement of 96.7% and a quadratic k of 0.84 (P<.001). A strong correlation was observed between BOT-8 and SDOT (r=0.67, P<.001) and UPSIT (r=0.86, P<.001). Agreement was excellent for disposable cotton swabs, with a k of 0.79 compared with the original test. The cut-off point for anosmia was ≤3 (area under the curve, 0.83; sensitivity, 0.673; specificity, 0.993). CONCLUSION: BOT-8 offers an efficient and fast method for assessment of smell threshold, detection, memory, and identification in daily clinical practice. Disposable cotton swabs with odorants proved to be useful and safe during the COVID-19 pandemic.


Subject(s)
COVID-19 , Olfaction Disorders , Adult , Anosmia , COVID-19/epidemiology , Humans , Odorants , Olfaction Disorders/diagnosis , Olfaction Disorders/epidemiology , Pandemics , Reproducibility of Results , Smell
3.
J Investig Allergol Clin Immunol ; 30(5): 346-357, 2020.
Article in English | MEDLINE | ID: covidwho-1000713

ABSTRACT

BACKGROUND AND OBJECTIVE: Since the initial anecdotal reports of coronavirus disease 2019 (COVID-19) from China, a growing number of studies have reported on smell and/or taste dysfunction (STD). Objective: The aim of our study was to investigate the frequency and severity of STD in COVID-19 patients and to evaluate the association with demographic characteristics, hospital admission, symptoms, comorbidities, and blood biomarkers. METHODS: We performed a multicenter cross-sectional study on patients who were positive for SARS-CoV-2 (n=846) and controls (n=143) from 15 Spanish hospitals. Data on STD were collected prospectively using an in-person survey. The severity of STD was categorized using a visual analog scale. We analyzed time to onset, recovery rate, time to recovery, hospital admission, pneumonia, comorbidities, smoking, and symptoms. RESULTS: STD was at least 2-fold more common in COVID-19-positive patients than in controls. COVID-19-positive hospitalized patients were older, with a lower frequency of STD, and recovered earlier than outpatients. Analysis stratified by severity of STD showed that more than half of COVID-19 patients presented severe loss of smell (53.7%) or taste (52.2%); both senses were impaired in >90%. In the multivariate analysis, older age (>60 years), being hospitalized, and increased C-reactive protein were associated with a better sense of smell and/or taste. COVID-19-positive patients reported improvement in smell (45.6%) and taste (46.1%) at the time of the survey; in 90.6% this was within 2 weeks of infection. CONCLUSION: STD is a common symptom in COVID-19 and presents mainly in young and nonhospitalized patients. More studies are needed to evaluate follow-up of chemosensory impairment.


Subject(s)
Betacoronavirus , Coronavirus Infections/complications , Coronavirus Infections/epidemiology , Olfaction Disorders/epidemiology , Olfaction Disorders/etiology , Pneumonia, Viral/complications , Pneumonia, Viral/epidemiology , Taste Disorders/epidemiology , Taste Disorders/etiology , Adult , Age Factors , Aged , Aged, 80 and over , Betacoronavirus/genetics , Betacoronavirus/immunology , COVID-19 , Case-Control Studies , Coronavirus Infections/diagnosis , Coronavirus Infections/virology , Cross-Sectional Studies , Female , Hospitalization , Humans , Male , Middle Aged , Olfaction Disorders/diagnosis , Pandemics , Pneumonia, Viral/diagnosis , Pneumonia, Viral/virology , Polymerase Chain Reaction , Public Health Surveillance , SARS-CoV-2 , Severity of Illness Index , Spain/epidemiology , Symptom Assessment , Taste Disorders/diagnosis , Young Adult
4.
Chemical Senses ; 45(6):491-492, 2020.
Article in English | Scopus | ID: covidwho-826485

ABSTRACT

This is a correction notice for article bjz034 (DOI: https://doi. org/10.1093/chemse/bjaa034), published on 22 May 2020. Due to an error in the script used to create subsections of Figure 1, there was both a shift in the intensity data and an erroneous calculation of error bars in all panels. Figure 1 and the accompanying figure legend have been revised to show the correct levels and error bars. This script error only affected visualization of the data in Figure 1 and did not impact the reported data or conclusions.(Figure Presented). © The Author(s) 2020. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

SELECTION OF CITATIONS
SEARCH DETAIL